Event Type
Disclosure
Mandatory
Variant
8-K
Material Modification to Rights of Security Holders. On January 27, 2026, the stockholders of Tempest Therapeutics, Inc., a Delaware corporation (the “ Company
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (e) On Januar
Submission of Matters to a Vote of Security Holders. On January 27, 2026, the Company held its 2025 Annual Meeting of Stockholders (the “ Annual Meeting ”). The